Anti-PD1 antibody: a new approach to treatment of lymphomas

被引：32
|
作者：
Bachy, Emmanuel [1 ,2 ,3 ]
Coiffier, Bertrand [1 ,2 ,3 ]
机构：
[1] Hosp Civils Lyon, Dept Hematol, Lyon, France
[2] Univ Lyon 1, Dept Hematol, F-69365 Lyon, France
[3] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 01期
关键词：
FOLLICULAR LYMPHOMA; T-CELLS; PD-1;
D O I：
10.1016/S1470-2045(13)70587-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [21] Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody
    Tej, Gullanki Naga Venkata Charan
    Neogi, Kaushik
    Nayak, Prasanta Kumar
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [22] Dermatologic adverse events during treatment with anti-PD1 inhibitors
    Benhuri, Benjamin
    Belum, V. R.
    Lacouture, Mario
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB116 - AB116
  • [23] Potential of New Therapies like Anti-PD1 in Kidney Cancer
    Gunturi, Anasuya
    McDermott, David F.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (01) : 137 - 146
  • [24] The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab
    Weichenthal, M.
    Mohr, P.
    Leiter-Stoeppke, U.
    Ugurel, S.
    Kaehler, K.
    Gutzmer, R.
    Pfoehler, C.
    Hassel, J. C.
    Nashan, D.
    Terheyden, P.
    Schell, B.
    Utikal, J. S.
    Kreuter, A.
    Haferkamp, S.
    Kaune, K.
    Berking, C.
    Debus, D.
    Ulrich, J.
    Dabrowski, E.
    Eigentler, T.
    Welzel, J.
    Herbst, R.
    Loquai, C.
    Meier, F.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 5 - 6
  • [25] Potential of New Therapies like Anti-PD1 in Kidney Cancer
    Anasuya Gunturi
    David F. McDermott
    Current Treatment Options in Oncology, 2014, 15 : 137 - 146
  • [26] Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
    Li, Xinying
    Wu, Guannan
    Chen, Cen
    Zhao, Yuan
    Zhu, Suhua
    Song, Xincui
    Yin, Jie
    Lv, Tangfeng
    Song, Yong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Germinal immunogenetics as a predictor of anti-PD1/PD-L1 treatment outcome.
    Milano, Gerard A.
    Refae, Sadal
    Ebran, Nathalie
    Gal, Jocelyn
    Otto, Josiane
    Drubay, Damien
    Chamorey, Emmanuel
    Ciccolini, Joseph
    Saada, Esma
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] VEDOLIZUMAB PLUS ANTI-PD1 ANTIBODY IN ADVANCED MELANOMA PATIENTS WITH INFLAMMATORY ENTEROCOLITIS
    Javed, Asad
    Freesmeier, Michele
    Zakharia, Yousef
    Milhem, Mohammed
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1313 - A1313
  • [29] Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
    Gjetting, Torben
    Gad, Monika
    Frohlich, Camilla
    Lindsted, Trine
    Melander, Maria C.
    Bhatia, Vikram K.
    Grandal, Michael M.
    Dietrich, Nikolaj
    Uhlenbrock, Franziska
    Galler, Gunther R.
    Strandh, Magnus
    Lantto, Johan
    Bouquin, Thomas
    Horak, Ivan D.
    Kragh, Michael
    Pedersen, Mikkel W.
    Koefoed, Klaus
    MABS, 2019, 11 (04) : 666 - 680
  • [30] Auranofin and the efficacy of anti-PD1 immunotherapy
    Zhang, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345